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1326 The Journal of Thoracic and CardBackground: We have recently demonstrated that remote ischemic preconditioning
reduces ischemia-reperfusion injury in animal models. The mechanisms by which
the remote ischemic preconditioning stimulus exerts its effect remain to be fully
defined, and its effect on myocardial gene expression is unknown. We tested the
hypothesis that remote ischemic preconditioning modifies myocardial gene expres-
sion immediately after the remote ischemic preconditioning stimulus (early phase)
and 24 hours later (late phase).
Methods: Twenty male (C57BL/6) 10- to 12-week-old mice were randomized into
4 groups: group 1 (control, early phase; n  5), group 2 (remote ischemic precon-
ditioning, early phase; n  5), group 3 (control, late phase; n  5), and group 4
(remote ischemic preconditioning, late phase; n  5). Groups 2 and 4 underwent
remote ischemic preconditioning induced by 6 cycles of 4 minutes of occlusion and
4 minutes of reperfusion of the femoral artery. Groups 1 and 2 were killed 15
minutes after completion of sham procedure or remote ischemic preconditioning,
and the hearts were removed and frozen in liquid nitrogen. Groups 3 and 4 were
killed 24 hours after remote ischemic preconditioning, and the hearts were harvested
in the same fashion. Gene expression was assessed by using the Affymetrix
MG-430A chip (Affymetrix, Santa Clara, Calif).
Results: Data filtering (P  .05, analysis of variance) and hierarchic 2-way clus-
tering identified significant differences in gene expression among the 4 groups.
Genes involved in protection against oxidative stress (eg, Hadhsc, Prdx4, and
Fabp4) and cytoprotection (Hsp73) were upregulated, whereas many proinflamma-
tory genes (eg, Egr-1 and Dusp 1 and 6) were suppressed.
Conclusion: A simple remote ischemic preconditioning stimulus modifies myocar-
dial gene expression by upregulating cardioprotective genes and suppressing genes
potentially involved in the pathogenesis of ischemia-reperfusion injury.
Ischemic preconditioning (IPC) is a potent innate mechanism of defense againstischemia-reperfusion (IR) injury. Both an early and a late phase of localischemic IPC can be induced in mice, with a significant reduction in subsequent
myocardial infarction size in response to prolonged ischemia.1 Modification of
myocardial gene expression has been described in murine models of local IPC,2,3
but there are no previous data examining genomic responses to IPC induced by a
remote stimulus. It is now known that myocardial IPC can be induced as a result of
brief ischemia of an organ or tissue remote from the heart. In previous rodent models
remote IPC (rIPC) was induced by using renal and mesenteric ischemia,4 as well as
infrarenal occlusion of the aorta.5,6 Although very effective at reducing myocardial
infarction, these methods are not easily applicable experimentally or in the clinical
arena. We have recently described a much simpler and noninvasive method of
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Pinducing rIPC using transient limb ischemia induced by
tourniquets or a standard blood pressure cuff.7,8 This novel
method prevented IR-induced endothelial dysfunction in
human subjects7 and reduced the extent of myocardial in-
farction in a porcine model by 40%.8 It also renders signif-
icant protection against IR injury in murine models.9,10
More germane to cardiac surgery are our preliminary ex-
perimental data regarding the ability of rIPC to modify
responses to cardiopulmonary bypass (CPB)–induced myo-
cardial, neuronal, and lung injury11 and our recent study
showing that rIPC of the recipient reduces IR injury in the
transplanted heart.12 The mechanisms by which rIPC exerts
its effects are unknown. We have recently demonstrated that
this rIPC stimulus modifies inflammatory gene expression
in circulating human leukocytes,13 but there are no data
regarding potential myocyte genomic responses to the rIPC
stimulus. In the present study we hypothesized that transient
lower-limb ischemia produces significant changes in myo-
cardial gene expression (ie, remotely from the site of
ischemia).
Methods
We performed a cross-sectional study in inbred mice to identify
myocardial responses to rIPC. The study protocol was approved by
the Animal Care and Use Committee of Toronto General Hospital
and was performed in accordance with the Guidelines of the
Canadian Council for Animal Care. Twenty inbred (C57BL/6),
male, 10- to 12-week-old mice weighing from 22.5 to 26 g (me-
dian, 24.1 g) were randomized into 4 groups. All mice were
anesthetized at the same time with a single intraperitoneal injection
of 90 mg/kg ketamine and 19 mg/kg xylazine (Rompun). All
animals were placed supine on the same warming blanket to keep
Abbreviations and Acronyms
CNBP  cellular nucleic acid–binding protein
CPB  cardiopulmonary bypass
DUSP  dual-specificity phosphatase
FABP  fatty acid–binding protein
GAPDH  glyceraldehyde-3-phosphate
dehydrogenase
HADHSC  L-3-hydroxyacyl-CoA dehydrogenase
HSP  heat shock protein
IPC  ischemic preconditioning
IR  ischemia-reperfusion
KIF  kinesin superfamily protein
PCR  polymerase chain reaction
PDGFRB  platelet-derived growth factor receptor 
PPAR  peroxisome proliferator–activated
receptor
rIPC  remote ischemic preconditioning
ROS  reactive oxygen species
SER  sarcoendoplasmic reticulumthe body temperature constant. Group 1 (control, early phase; n 
The Journal of Thoracic5) and group 2 (rIPC, early phase; n  5) were studied to evaluate
the early effect of the rIPC stimulus. Group 3 (control, late phase;
n  5) and group 4 (rIPC, late phase; n  5) were studied to
evaluate the late effect of the rIPC stimulus. To that end, groups 2
and 4 underwent 6 cycles of 4 minutes of femoral artery occlusion
and 4 minutes of reperfusion. Unilateral limb ischemia was
achieved noninvasively by applying direct pressure to the femoral
vessels at the inguinal level without skin transgression. Venous
congestion was observed during occlusion, followed rapidly by
brisk reactive hyperemia during reperfusion, with 3.5 magnify-
ing surgical glasses. The reproducibility and reliability of the
method of mice lower-limb ischemia has been verified by means of
pulse oxymetry modified for application in mice. The timing of
this IPC protocol was chosen to reproduce a previously reported
effective local IPC method, which was shown to reduce infarction
size in a mouse by 75% when the 30-minute left anterior descend-
ing coronary artery occlusion was performed 10 minutes after the
local IPC and by 48% when the left anterior descending coronary
artery occlusion was performed 24 hours after the IPC.1 Animals
in groups 1 and 2 were killed 15 minutes after completion of the
rIPC or sham procedure. The chest was opened promptly. The
heart was removed and frozen in liquid nitrogen. There was no
overt limb damage in the remaining 10 animals (groups 3 and 4),
and they had uneventful recovery. Animals in groups 3 and 4 were
killed 24 hours later immediately on induction of the same anes-
thesia, and the heart was harvested.
RNA Isolation
Total RNA was isolated from 20 heart samples with Trizol Re-
agent (GIBCO/BRL), according to the manufacturer’s protocol.
The quality of total RNA was assessed with the Agilent 2100
Bioanalyzer (version A.02.01S1232, Agilent Technologies). Only
RNA with an optical density ratio of 1.99 to 2.0 at 260/280 was
used.
Affymetrix GeneChip Hybridization and Staining
A total of 20 hybridizations were performed on the MG-430A
mouse GeneChip set (Affymetrix) with the 20 total RNAs from
heart samples of 5 mice from each of the 4 different groups (5
early-phase control, 5 early-phase rIPC, 5 late-phase control, and
5 late-phase rIPC). Samples were prepared for hybridization ac-
cording to standard Affymetrix instructions and performed at the
Genomic core center at the Hospital for Sick Children. Briefly, a
primer encoding the T7 RNA polymerase promoter linked to
oligo-dT17 was used to prime double-stranded cDNA synthesis
from each mRNA sample by using Superscript II RNase H-reverse
transcriptase (Life Technologies). Each purified (Qiaquick kit,
Qiagen) double-stranded cDNA was transcribed in vitro by using
T7 RNA polymerase (T7 kit, Enzo Biochemicals), incorporating
biotin-UTP (Enzo) into the cRNAs followed by purification with
RNEasy (Qiagen), and quantitated by measuring absorption at 260
nm/280 nm. Samples were fragmented and hybridized to the
GeneChip for 16 hours at 45°C and scanned (GeneArray scanner,
Affymetrix). MicroArray Suite Version 5 (Affymetrix) was used to
scale intensities across the GeneChip sets to 150 fluorescence units
and to determine expression values for each gene on the chip. The
expression value for each gene was determined by calculating the
and Cardiovascular Surgery ● Volume 130, Number 5 1327
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intensity) of the probe pairs in use for the gene.
Experimental design, gene lists, hierarchic trees, chip hybrid-
ization, and statistical analysis were done in compliance with
the Minimum Information About a Microarray Experiment
guidelines.14
Affymetrix GeneChip Data Analysis
Gene analysis software. Data analysis was performed with
GeneSpring (Silicon Genetics).
Data analysis. Scanned raw data were processed with Af-
fymetrix Microarray Suite version 5.0 software. The average in-
tensity value for each probe set, which directly correlates with
mRNA abundance, was calculated as an average of fluorescence
differences for each perfectly matched versus single nucleotide–
mismatched probe. To test the integrity of the starting RNA, we
examined the signal intensity ratio for the 3= probe set over the 5=
probe set for the housekeeping genes -actin and glyceraldehyde-
3-phosphate dehydrogenase (GAPDH). For the 13 arrays used in
this study, the 3=/5= ratios were 1.3  0.07 and 0.97  0.06 for
-actin and GAPDH, respectively. Once sample quality was dem-
onstrated, those genes with consistently present calls were consid-
ered. Data obtained from MAS 5.0 absolute analyses of all the
individual arrays were analyzed and clustered with GeneSpring to
monitor the expression of chosen genes over the different exper-
imental time points (http://www.silicongenetics.com).
GeneSpring 6.1 was then used for normalization, each sample
was normalized to its control (untreated), and then genes were
filtered first on the basis of a P value of less than .05, 1-way
analysis of variance (not equal variance) was performed on these
genes, and finally 1.5-fold upregulated or downregulated genes in
the rIPC groups versus the control groups generated 166 genes,
which were used for hierarchic clustering (Figure 1). Each sample
1328 The Journal of Thoracic and Cardiovascular Surgery ● Novwas analyzed individually, and none of the methods was applied to
pooled data. Global normalization was performed, and all intensi-
ties across the GeneChips were scaled. In addition to global
normalization, we normalized each sample to its control to remove
the biologic variation.
Microarray Validation
The microarray results were confirmed by using real-time quantitative
polymerase chain reaction (PCR) on 4 randomly selected genes that
demonstrated significantly altered gene expression. Predesigned
FAM-labeled TaqMan primer sets for mice were ordered against the
following: dual-specificity phosphatase (DUSP) 1 (Mm00457274_m1),
heat shock 70-kd protein 5 (Mm00517691_m1), peroxiredoxin 4
(Mm_00450261_m1), and L-3-hydroxyacyl-coenzyme A dehy-
drogenase (Mm_00492535_m1; Applied Biosystems).
Amplicon abundance was determined in real time normalized
against a GAPDH control. Fold changes were determined as a ratio
of sample biopsy RNA to that of the average RNA expression in
preischemic biopsy specimens.
Total cDNA was synthesized in a 2-step reverse transcriptase–
PCR protocol by using Superscript First-Strand Synthesis System
for reverse transcriptase–PCR (Invitrogen catalog no. 11904-018).
RNA (1.5 g) was added to 1 L of 10 mmol/L deoxyribonucleo-
side triphosphate mix and Oligo(dT)12-18 (0.5 g/L) up to a
10-L volume with water treated with diethylpyrocarbonate.
Primer annealing was initiated by heating the reaction mix to 65°C
for 5 minutes and cooling to 4°C, after which 9 L of 10 RT
Buffer, 25 mmol/L MgCl2, 0.1 mol/L dithiothreitol, and RNAse
Out was added and incubated at 42°C for 2 minutes. The final step
was initiated by adding 1 L of SuperScript II RT and allowed to
run for 50 minutes at 42°C.
Quantitative real-time PCR was performed on 3.6 ng of total
Figure 1. Hierarchic clustering of differen-
tially expressed genes in control animals and
after remote ischemic preconditioning (IPC).
Data filtering and 2-way hierarchic cluster
analysis identified 166 genes that were dif-
ferentially expressed. Gene expression levels
are depicted as color variation from red (high
expression) to blue (low expression). The
color in each cell of the figure displays the
level of expression for each gene (columns)
in the myocardium of each individual animal
(row).cDNA per well. For each gene of interest, TaqMan Assay-on-
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PDemand (Applied Biosystems catalog no. 4331182) was mixed
with TaqMan Master Mix, and 15 L was loaded per well to a final
reaction volume of 25 L. Each sample was run in triplicate on the
ABI Prism 7000 detection system (Applied Biosystems). Calcula-
tion of relative quantities of the various products was determined
by using the CT method (http://docs.appliedbiosystems.com/
pebiodocs/04303859.pdf) relative to human GAPDH.
Results
General unsupervised clustering of global gene expression
in the 20 mice demonstrated clear delineation of each of the
4 groups (Figure 1). Data filtering (P  .05, analysis of
variance) and hierarchic 2-way clustering identified signif-
icant changes in the expression of 166 genes. The quanti-
tative PCR confirmed the microarray results of all 4 ran-
domly selected genes. The changes in expression of 19
genes with the greatest fold change between at least 2
groups are listed in Table 1. It is important to note that the
expression of some genes changed significantly after intra-
peritoneal injection of anesthetic and the associated stress of
anesthesia. For example, gene expression of Egr-1, a gene
that has a central role in the pathogenesis of ischemic
TABLE 1. Myocardial gene expression patterns after remo
GenBank no. Affymetrix no. Gene name
Immediate early response genes
NM_007913 1417065 Early growth response 1
AV299745 1437850 Cellular nucleic acid–binding protein
Phosphatase genes
NM_013642 1448830 Dual-specificity phosphatase 1
NM_026268 1415834 Dual-specificity phosphatase 6
BB816770 1456462 Protein phosphatase 1, cb
Heat shock protein genes
NM_022310 1416064 Heat shock 70-kd protein 5
AK010861 1423151 DnaJ (Hsp40) homolog
BC006722 1420622 Heat shock 70-kd protein 8
Oxidative stress response genes
BF319868 1423423 Glucose-regulated protein 58
NM_016764 1416166 Peroxiredoxin 4
BB114220 1436756 L-3-hydroxyacyl-CoA dehydrogenase
NM_00880 1417148 Platelet-derived growth factor
receptor
BC002148 1451263 Fatty acid–binding protein 4
Mitochondrial function gene
AK014590 1418428 Kinesin family member 5B
TNF signaling gene
NM_013749 1418572 TNF receptor 12
Genes with unknown function
BB483357 1438651 Angiotensin receptor-like 1
AK014338 1428112 Arginine rich
AK018378 1423420 Adrenergic receptor, 1
NM_02638 1416187 DNA segment, Chr4
IPC, Ischemic preconditioning; CoA, coenzyme A; TNF, tumor necrosis facdamage, increased 4-fold in the control group (group 3) 24
The Journal of Thoracichours after anesthesia-induced stress. Conversely, although
there was no difference in Egr-1 expression 15 minutes after
rIPC compared with control (group 1 vs group 2), Egr-1
gene expression was significantly lower 24 hours after rIPC
(group 3 vs group 4, Table 1). There was also significant
differential expression of the genes involved in response to
oxidative stress, inflammation, and mitochondrial function.
Discussion
This study shows that transient limb ischemia modifies
genomic responses in remote organs and, specifically, mod-
ifies genes responsible for myocardial responses to inflam-
matory or oxidation-induced stress. The results of our study
are consistent with the recent findings of Li and col-
leagues,10 who detected nuclear translocation of nuclear
factor B in both heart and preconditioned skeletal muscle
after transient hind-limb ischemia and demonstrated that
gene expression is essential for myocardial protection in
mice. The potential relevance of some of the observed
genomic responses to the ischemic protection rendered by
the rIPC stimulus in coronary ischemic syndromes and the
chemic preconditioning
ne symbol
Group 1 Group 2 Group 3 Group 4
Control, early IPC, early Control, late IPC, late
r-1 0.74 0.32 0.76 0.16 2.82 0.98 1.15  0.17
bp 0.71 0.16 1.37  0.15 0.85 0.18 1.42  0.39
sp1 0.88 0.21 0.78 0.16 2.4  0.45 1.14  0.34
sp6 0.69 0.19 0.89  0.18 1.67 0.2 1.25  0.2
p1cb 0.81 0.21 1.16  0.3 0.72 0.18 1.35  0.19
pa5,Grp78 0.96 0.16 0.75 0.14 2.56 0.87 1.23  0.63
ajb11 0.92 0.16 0.97  0.2 2.96 0.66 1.15  0.33
pa8,Hsp73 0.75 0.15 1.77  0.39 0.82 0.23 1.13  0.4
p58 1.04 0.16 0.85 0.14 2.28 0.59 1.16  0.55
dx4 0.72 0.4 1.33  0.39 0.74 0.45 1.4  0.41
dhsc 0.4 0.27 1.41 0.2 0.49 0.37 1.35  0.27
gfrb 1.21 0.35 0.59  0.18 1.08 0.2 0.87  0.25
bp4 0.67 0.16 1.29  0.18 0.77 0.17 1.36  0.22
5b 0.75 0.24 1.53 0.36 0.75 0.26 1.39  0.33
frsf12a 1.86 0.28 1.33 0.8 1.28 0.45 0.62  0.32
trl1 0.71 0.25 0.54 0.18 2.14 0.35 1.38  0.58
met 0.98 0.16 0.79  0.15 6.13 2.4 2.25  1.9
rb1 0.6 0.26 1.14 0.24 1.04 0.52 1.21  0.41
Bwg05 0.68 0.17 1.46  0.2 0.68 0.18 1.46  0.23te is
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D4IR injury of cardiac surgery is discussed below.
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The Egr-1 gene is of particular interest because it is a master
switch coordinating upregulation of divergent gene families
underlying ischemic stress.15 Growth factors and cytokines,
including platelet-derived growth factor, angiotensin II, and
tumor necrosis factor, increase Egr-1 gene expression
within 15 minutes.16 Egr-1, in turn, activates transcription
of several genes involved in the pathogenesis of ischemic
tissue damage.15 We observed a 4-fold increase in Egr-1
gene expression 24 hours after intraperitoneal injection of
anesthetic. Bearing in mind that anesthesia is a relatively
minor stress, our results are consistent with the observations
of others. For example, a 3-fold increase in Egr-1 gene
expression was observed in the ischemic lungs of wild-type
mice within 15 minutes, increasing 10-fold by 1 hour of
ischemia and 20-fold after 3 hours of reperfusion.15 Inter-
estingly, rIPC diminished Egr-1 upregulation by approxi-
mately 2.5-fold (Table 1). We have previously demon-
strated significant upregulation of myocardial Egr-1 during
cardiac ischemia in neonates compared with that seen in
older children.17 We speculated that this in part might be
one of the factors contributing to increased vulnerability of
neonatal myocardium to IR.18 The current data are also
consistent with the previously observed association of Egr-1
induction and activation with renal and cardiac ischemia.
Furthermore, lung IR injury, as assessed on the basis of
fibrin deposition, leukocyte accumulation, and vascular per-
meability, is significantly diminished in Egr-1–null mice
compared with wild-type mice.16 Indeed, it was previously
suggested, in view of the relatively intact phenotype of
Egr-1–null mice, that short-term antagonism of Egr-1 might
provide a novel therapeutic target to diminish maladaptive
host responses incited by acute ischemia.16 However, this
aim might be achieved primarily by rIPC, which signifi-
cantly decreased upregulation of Egr-1 gene expression at
24 hours.
We also observed rapid upregulation of cellular nucleic
acid–binding protein (CNBP) by rIPC. Its striking conser-
vation in phylogenically diverse organisms suggests that
CNBP plays a fundamental biologic role across different
species. Consistent with its function as a transcription fac-
tor, CNBP protein is located in the nucleus of cells. The
physiologic properties of the CNBP gene are unknown.19
However, it was recently reported that overexpression of
CNBP strongly stimulates cell proliferation in mice.19
Phosphatases
Phosphatases, including protein phosphatases and DUSPs,
are key elements in cellular responses to IR injury.20,21 The
precise role of DUSPs in IR injury, however, is not defined.
Nonetheless, it was recently demonstrated that gene expres-
sion of DUSP-1 (MKP-1) increased 12-fold in patients
immediately after CPB and cardioplegic arrest,21 suggesting
1330 The Journal of Thoracic and Cardiovascular Surgery ● Novinvolvement of DUSP-1 in CPB-induced systemic inflam-
matory response. Although DUSP-1 gene expression is up-
regulated in response to hypoxia and IR,21 it might also
have some protective properties.22 In contrast, DUSP-6
(MKP-3) is known to mediate dephosphorylation of extra-
cellular signal-regulated kinases 1 and 2, which in turn leads
to the degradation of Bcl-2 and increased apoptosis.23 In the
present study DUSP-1 gene expression increased almost
3-fold in response to the anesthesia-induced stress in mouse
myocardium, and rIPC significantly attenuated the extent of
this upregulation. A similar trend was observed for
DUSP-6. Furthermore, myocardial protein phosphatase 1
gene expression was unchanged in control animals but was
upregulated after rIPC (Table 1).
Heat Shock Protein Genes
Heat shock 70-kd protein 5 (Hspa 5, Grp78) and protein 8
(Hspa 8, Hsp 73) are 2 important members of the heat shock
protein (HSP) 70 family. Involvement of HSP70 gene ex-
pression in murine2,24 and canine25 hearts by local IPC has
previously been demonstrated. In the present study, both
Grp78 and Hsp 40 (Dnajb11) were upregulated in response
to anesthesia at 24 hours, but much less so after rIPC (Table
1). In contrast, HSP73 was significantly upregulated 15
minutes after rIPC and remained upregulated at 24 hours.
Thus our data demonstrate differential expression of mem-
bers of the HSP70 family by rIPC and are compatible with
the local IPC gene expression studies performed by Sergeev
and associates26 in rat hearts using similar Affymetrix mi-
croarray methodology. The latter study of local IPC re-
vealed trigger-dependent differential transcription of
HSPs26 and demonstrated that both remote and local IPC
can stimulate expression of different members of the HSP70
family.
Oxidative Stress Response Genes
The expression pattern of several genes involved in the
oxidative stress response was modified by rIPC. The third
step in the mitochondrial -oxidation spiral of short-chain
fatty acids is catalyzed by short-chain L-3-hydroxyacyl-
CoA dehydrogenase (HADHSC). Patients with HADHSC
deficiency have defective fatty acid oxidation. HADHSC
gene expression was increased more than 3-fold by rIPC
and remained at this level at 24 hours (Table 1). This might
be a mechanism by which intracellular energy production is
preserved during a subsequent IR insult. Peroxiredoxins are
potent antioxidants evolved to protect cells from damage by
reactive oxygen species (ROS) after IR injury.27 Peroxire-
doxin 4 is a secretable protein and might exert its protective
function against oxidative damage by scavenging ROS in
the extracellular space. We observed rapid upregulation of
peroxiredoxin 4 gene expression that persisted for 24 hours
after rIPC. Intracellular protection against ROS is mediated
ember 2005
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Pin part by glucose-regulated protein 58 (also known as
Erp57), which is a luminal protein of the sarcoendoplasmic
reticulum (SER). Glucose-regulated protein 58 modulates
the redox state of SER, providing control of SER Ca2
homeostasis.28 Remote IPC reduced the upregulation in
response to general anesthesia seen in the control animals at
24 hours. Similarly, platelet-derived growth factor receptor
 (PDGFRB) is an important oxidative molecule with
serine-threonine kinase activity, which is postulated to play
a critical role in the pathogenesis of atherosclerosis.29 Inhi-
bition of PDGFRB results in significant reduction of oxida-
tive stress. Flavonoids of the catechin family, which are
found, for example, in red wine, are potent inhibitors of
PDGFRB signaling and have been implicated in slowing pro-
gression of oxidative endothelial damage.29 We demonstrated,
for the first time, that rIPC rapidly suppresses PDGFRB gene
expression (2-fold in 15 minutes), and it remains low at 24
hours (Table 1).
Fatty acid–binding protein (FABP) 4 binds fatty acids
and transports them to the nucleus, where the FABP4–fatty
acid complex activates peroxisome proliferator–activated
receptor (PPAR) . PPAR is a transcription factor that
regulates genes involved in lipid and glucose metabolism.
Activation of PPAR gene expression after local IPC was
observed in rat hearts.2 FABP4 appears to play an important
role in cardiovascular diseases. Its rapid increase after IR
injury has been recently used as a prognostic marker.30 In
our study FABP4 gene expression was increased 2-fold by
the rIPC both early and 24 hours later.
Mitochondrial Locomotion Gene
The kinesin superfamily proteins (KIFs) have been shown
to transport organelles, protein complexes, and mRNA to
their specific intracellular destinations. Conventional kine-
sin (KIF5) is a tetramer of 2 kinesin heavy chains and 2
kinesin light chains. Kinesin heavy chains form a structur-
ally and functionally closely related family (KIF5A, KIF5B,
and KIF5C). KIB5B is expressed ubiquitously throughout
many tissues, whereas KIF5A and KIF5C are specific to
nerve tissue. Mouse kinesin family member 5B (KIF5B) is
associated with mitochondria. KIF5B-null mice are embry-
onically lethal, with severe growth retardation at 10 days
after conception.31 Mitochondria of extraembyronic KIF5B-
null mutant cells are abnormally clustered in the perinuclear
region.31 Similar abnormal perinuclear clustering of mito-
chondria from an evenly spread distribution throughout the
cytoplasm is caused by tumor necrosis factor  in normal
cells.32 It was recently shown that activation of tumor
necrosis factor receptor 1 results in hyperphosphorylation of
kinesin light chains and inhibition of kinesin activity.32
Although there was no detectable change in KIF5B expres-
sion in control animals, the KIF5B gene expression doubled
The Journal of Thoracic15 minutes after rIPC and remained high in rIPC animals 24
hours later.
Conclusion
In summary, transient limb ischemia induces important
global myocardial genomic responses that are compatible
with increased resistance to ischemic and oxidative stress
both early and late after the stimulus. This study was not
designed to describe the nature of the signaling of the rIPC
stimulus but provides data on which further studies can be
based. Subsequent studies must also address the functional
implications of these genomic responses, both at a transcrip-
tional and proteomic level. Nonetheless, this simple method
of inducing IPC remotely will facilitate future investigations
of this potentially clinically valuable technique.
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